Ray Dalio Teva Pharmaceutical Industries LTD Transaction History

Bridgewater Associates, LP

$18.9 Billion
Q2 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bridgewater Associates, LP holds 22,078 shares of TEVA stock, worth $386,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,078

Previous 46,661 52.68%

Holding current value

$386,365

Previous $658,000 45.59%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $314,170 - $427,744	-24,583 Reduced 52.68%	22,078 $358,000
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $281,826 - $381,139	-26,413 Reduced 36.15%	46,661 $658,000
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $986,182 - $1.29 Million	-121,451 Reduced 62.43%	73,074 $762,000
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $284,127 - $406,439	-37,985 Reduced 16.34%	194,525 $1.98 Million
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $72,986 - $95,997	-10,137 Reduced 4.18%	232,510 $1.75 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $558,197 - $759,174	-66,770 Reduced 21.58%	242,647 $2.15 Million
Q4 2022 Feb 13, 2023	SELL	$7.95 - $9.48 $1.07 Million - $1.28 Million	-134,841 Reduced 30.35%	309,417 $2.82 Million
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $279,785 - $487,380	-40,785 Reduced 8.41%	444,258 $3.59 Million
Q2 2022 Aug 11, 2022	SELL	$7.38 - $10.4 $416,755 - $587,298	-56,471 Reduced 10.43%	485,043 $3.65 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $160,490 - $205,594	21,895 Added 4.21%	541,514 $5.09 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $1.93 Million - $2.49 Million	244,402 Added 88.8%	519,619 $4.16 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $281,132 - $341,518	33,548 Added 13.88%	275,217 $2.68 Million
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $2.39 Million - $2.79 Million	241,669 New	241,669 $2.39 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $344,324 - $562,624	-23,600 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $50,544 - $61,560	2,400 Added 11.32%	23,600 $508,000
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $108,420 - $143,455	-6,500 Reduced 23.47%	21,200 $362,000
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $426,857 - $891,109	27,700	27,700 $488,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account